Le Lézard
Classified in: Transportation, Health, Business
Subject: ACC

Nordic Nanovector ASA: Increased Share Capital Following Exercise of Employee Share Options


OSLO, Norway, March 18, 2019 /PRNewswire/ -- An individual participant in Nordic Nanovector ASA's (the "Company") (OSE:NANO) previous share option program, not being a primary insider, has exercised a total number of 17,392 options through exercise of a corresponding number of free-standing warrants. 14,374 of the options are exercised at a strike price of NOK 30.00 per share, and 3,018 of the options are exercised at a strike price of NOK 14.24. Each free-standing warrant gives the right to receive one share in the Company.

Following exercise of the 17,392 free-standing warrants, the Company's registered share capital was increased by NOK 3,478.40 through issuance of 17,392 new shares, each with a nominal value of NOK 0.20, against payment of a total subscription price of NOK 474,196. Following the share capital increase the Company has a share capital of NOK 10,937,520.60 divided on 54,687,603 shares, each with a par value of NOK 0.20.

About Nordic Nanovector:

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.

Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37 -targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 29 billion by 2026. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.

Further information can be found at www.nordicnanovector.com.

This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Malene Brondberg,
VP Investor Relations and Corporate Communications
Cell: +44-7561-431-762
Email: [email protected]  

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/nordic-nanovector/r/nordic-nanovector-asa--increased-share-capital-following-exercise-of-employee-share-options,c2765353

 

SOURCE Nordic Nanovector


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 18:15
Consolidated Financial Highlights (unaudited) (in thousands of dollars except per shareamounts)Three months endedMarch 31,2024March 31,2023Net loss(701)(8,051)Basic and diluted loss per share(0.03)(0.33) Operating Data  Three months...

at 18:12
Yeshiva University, the nation's flagship Jewish University for over 140 years, today announced that in light of ongoing antisemitism and harassment on college campuses, YU is reopening its transfer portal for undergraduate applicants,...

at 18:10
NOV Inc. today reported first quarter 2024 revenues of $2.16 billion, an increase of 10 percent compared to the first quarter of 2023. Net income was $119 million, or 5.5 percent of sales, a decrease of $7 million compared to the first quarter of...

at 18:10
Ohio Valley Banc Corp. [Nasdaq: OVBC] (the "Company") reported consolidated net income for the quarter ended March 31, 2024, of $2,793,000, a decrease of $1,115,000, or 28.5%, from the same period the prior year. Earnings per share for the first...

at 18:07
Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Klein Square in Spring, Texas on May 18th. "We are thrilled to open our store at Klein Square," said Jack...



News published on and distributed by: